PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
57.82
ESG score 80-90% of EYEN's 71.63. Walter Schloss would scrutinize governance quality and regulatory exposure.
56.22
Environmental score 80-90% of EYEN's 69.43. Walter Schloss would scrutinize carbon exposure and transition planning.
57.56
Social score 80-90% of EYEN's 67.29. Walter Schloss would scrutinize stakeholder relations and reputational exposure.
59.67
Governance score below 80% of EYEN's 78.18. Jim Chanos would check for potential agency conflicts and oversight failures.